Clemastine fumarate as an antipruritic agent in pruritic cats: results of an open clinical trial.
Clemastine fumarate was administered to 10 presumed or proven atopic cats to determine its efficacy in controlling their pruritus. Initially, each cat received 0.34 mg orally every twelve hours for 14 days. When none responded satisfactorily, the dosage was increased to 0.68 mg/cat every twelve hours. At that dosage, the pruritus in five cats (50%) was eliminated. Diarrhea was seen in one cat. Under the conditions of the study, clemastine was a useful antipruritic agent for the cat.
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853.
W H
WH
Miller
D W
DW
Scott
D000284:Administration, Oral; D000818:Animals; D002371:Cat Diseases / Q000517:prevention & control*; D002415:Cats; D002974:Clemastine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D008297:Male; D011537:Pruritus / Q000517:prevention & control / Q000662:veterinary*; D016896:Treatment Outcome
D002974:Clemastine